Comments
Caplin Point Laboratories on Thursday said that its plant at Puducherry has commenced its additional line of production of suppositories - a unique feature which only a few pharmaceutical companies have. This will enable the company to export these products to semi- and non-regulated markets, including Dominican Republic, Guatemala, Nicaragua, El Salvador, Honduras, Angola and Mali. Shares of Caplin Point closed at ₹264.95, up 4.35 per cent on the NSE.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.